Cardiac Rehabilitation for the Patients With Acute Myocardial Infarction

Sponsor
Taipei Medical University WanFang Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05661825
Collaborator
(none)
500
7.5

Study Details

Study Description

Brief Summary

The benefits of cardiac rehabilitation include improving exercise tolerance and quality of life. However the attending rate of the patients with acute myocardial infarction was low according to the previous studies. This is a retrospective chart review study collecting the basic characteristics of the patients diagnosed with acute myocardial infarction of Wang-Fang Hospital (from Jan 1, 2012 to June 30, 2021). The aims of the studies are to investigate the related issues of cardiac rehabilitation including (1) attending rate (2) the efficacy of exercise training (3) the factors that limit the participation of the training programs.

Condition or Disease Intervention/Treatment Phase
  • Other: phase II cardiac rehabilitation

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
The Efficacy and Related Factors in Phase II Cardiac Rehabilitation for the Patients With Acute Myocardial Infarction
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Aug 18, 2023
Anticipated Study Completion Date :
Aug 18, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients diagnosed with acute myocardial infarction in the emergent department

The cases being admitted to the Emergent Department and than transferred to the general ward due to the diagnosis of acute myocardial infarction were included in the study (from Jan 1, 2012 to Jun 30, 2022). The age of these cases must be older than or equal to 20 years old.

Other: phase II cardiac rehabilitation
Phase II cardiac rehabilitation was provided in the the department of physical medicine and rehabilitation in Wan Fang Hospital. The programs are two times a week, one session for 30 minutes (30 sessions in total). The training programs are focused on aerobic training with bicycles. The training intensity is calculated with 40% to 80% oxygen consumption reserve from the result of cardiopulmonary exercise test. In case of safety, heart rate, blood pressure, EKG and rate of perceived exertion will be monitored during training.

Outcome Measures

Primary Outcome Measures

  1. Efficacy of phase II cardiac rehabilitation [Baseline, 6 weeks after training, 16 weeks after training]

    The changes of maximal oxygen consumption after intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • The cases being admitted to the Emergent Department and than transferred to the general ward due to the diagnosis of acute myocardial infarction were included in the study (from Jan 1, 2012 to Jun 30, 2022). The age of these cases must be older than or equal to 20 years old.
Exclusion Criteria:
  1. AAD cases after admission to ER or the general ward

  2. Cases died within admission.

  3. Cases refused the treatments.-

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Taipei Medical University WanFang Hospital

Investigators

  • Principal Investigator: Shiauyee Chen, Master, Department of physical medicine and rehabilitation, Wan Fang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT05661825
Other Study ID Numbers:
  • TMU-JIRB N202207042
First Posted:
Dec 22, 2022
Last Update Posted:
Dec 22, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Taipei Medical University WanFang Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 22, 2022